Xarelto Lawsuit Multidistrict Litigation Sets Dates For 2017 Bellwether Trials

December 31, 2015 – – BloodThinnerHelp.com reports on the latest news regarding bellwether trials for lawsuits involved in Xarelto multidsitrict litigation number 2592. The MDL is being overseen in the Eastern District of Louisiana by Judge Eldon Fallon.

The Honorable Judge Fallon has ordered that starting the new year (2016) bellwether trial selections will begin from a pool of over 40 complaints containing similar allegations. Of this larger pool, only 4 cases will be chosen to be heard during bellwether trials. According to recent announcements, the first 2 of 4 cases will be heard in the U.S. District Court for the Eastern District of Louisiana, while the 3rd will be heard in Mississippi and the 4th in Texas. These bellwether trials are designed to give both defendants and plaintiffs an idea of how a jury may respond to future trials.

Dates for these bellwether trial cases have also been announced. The initial two cases are currently scheduled for February 6, 2017 and March 13, 2017, the 3rd case is scheduled to be heard on April 24th of 2017, and the final is scheduled for May 30, 2017. The cases involved in the MDL now number approximately 2,200, and similarly allege that blood thinning drug Xarelto can cause dangerous uncontrollable bleeding episodes in patients taking it.

Plaintiffs additionally allege that Xarelto manufacturers Janssen Pharmaceuticals (a division of Johnson & Johnson), and Bayer AG were negligent to release an anticoagulant to the market with no corresponding antidote to accompany it. Despite the fact that Xarelto has now been on the market for over 4 years, the companies have yet to offer an antidote for patients.

Xarelto’s lack of antidote can turn even a small injury into a dangerous situation. When someone with Xarelto in their system begins to bleed, that blood is unable to clot. In these instances, the patient can quickly lose too much blood, and therefore would require life-saving treatments, such as blood transfusions or surgery.

Patients who use traditional blood thinners do not have this issue, as they have an antidote available through vitamin K. If someone taking a traditional blood thinner begins to bleed, physicians can make their blood clot by treating them with vitamin K. This can be a lifesaving difference in emergency situations.

Attorney Joseph Osborne understands the great risks surrounding Xarelto. He is currently working to ensure that everyone affected by the drug will have the opportunity to evaluate their legal rights. As cases prepare for trial, others will likely be able to join them. People who have suffered after using Xarelto may be entitled to legal action and significant compensation. Attorney Osborne is offering free legal consultations for affected individuals at this time.

To ask questions about the Xarelto uncontrollable bleeding lawsuits, or request additional information on the topic, please contact Joseph Osborne, Esq. by calling (866) 425-8902.

###

Contact BloodThinnerHelp.com:

Joseph Osborne
866-425-8902
Mizner Park
433 Plaza Real Blvd., Ste. 271
Boca Raton, FL 33432

ReleaseID: 60006828